Fremont, California (Press Release)— March 31, 2006—VM Discovery Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program. Under the collaboration, VMDI will use its proprietary multi-property drug design and optimization technology platform, the “VM OptimizerTM, to generate and optimize small-molecule ”drug-like” leads and clinical candidates, while the Hutchinson Center will leverage its expertise in cancer biology and proprietary technologies. Other terms of the collaboration were not disclosed.
